Deyue Liu

No. 100 Haining Road
Hongkou, 200080, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Oncological outcome of endoscopic nipple-sparing mastectomy versus conventional open mastectomy in early breast cancer: a multicenter cohort study.

Oncological outcome of endoscopic nipple-sparing mastectomy versus conventional open mastectomy in early breast cancer: a multicenter cohort study.

Journal: World journal of surgical oncology
Published: May 17, 2026

Serum IL2Rα as a Diagnostic Biomarker and Its Functional Interplay With IL-2 in Breast Cancer.

Serum IL2Rα as a Diagnostic Biomarker and Its Functional Interplay With IL-2 in Breast Cancer.

Journal: The breast journal
Published: January 27, 2026

Loss of FAM134B increased endoplasmic reticulum stress and induced cell autophagy in breast cancer.

Loss of FAM134B increased endoplasmic reticulum stress and induced cell autophagy in breast cancer.

Journal: Frontiers in immunology
Published: June 24, 2025

Anthracycline-Free Neoadjuvant Therapy With Nab-Paclitaxel and Carboplatin in Non-Luminal Breast Cancer: A Single-Arm Clinical Trial.

Anthracycline-Free Neoadjuvant Therapy With Nab-Paclitaxel and Carboplatin in Non-Luminal Breast Cancer: A Single-Arm Clinical Trial.

Journal: International journal of cancer
Published: June 10, 2025

Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression.

Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression.

Journal: BMC cancer
Published: October 09, 2022

The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial.

The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial.

Journal: Cancers
Published: June 01, 2022

Molecular subtypes predict the prognosis of male breast cancer: a retrospective cohort study.

Molecular subtypes predict the prognosis of male breast cancer: a retrospective cohort study.

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer
Published: May 20, 2022

Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer.

Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer.

Journal: Breast cancer (Tokyo, Japan)
Published: February 07, 2022

Impact of Different Modules of 21-Gene Assay in Early Breast Cancer Patients.

Impact of Different Modules of 21-Gene Assay in Early Breast Cancer Patients.

Journal: Frontiers in endocrinology
Published: August 16, 2021

Combined Estrogen Receptor and Progesterone Receptor Level Can Predict Survival Outcome in Human Epidermal Growth Factor Receptor 2-positive Early Breast Cancer.

Combined Estrogen Receptor and Progesterone Receptor Level Can Predict Survival Outcome in Human Epidermal Growth Factor Receptor 2-positive Early Breast Cancer.

Journal: Clinical breast cancer
Published: December 28, 2020

Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study.

Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study.

Journal: Frontiers in oncology
Published: July 04, 2020

Validation of the Prognostic Stage of American Joint Committee on Cancer Eighth Edition Staging Manual in Invasive Lobular Carcinoma Compared to Invasive Ductal Carcinoma and Proposal of a Novel Score System.

Validation of the Prognostic Stage of American Joint Committee on Cancer Eighth Edition Staging Manual in Invasive Lobular Carcinoma Compared to Invasive Ductal Carcinoma and Proposal of a Novel Score System.

Journal: Frontiers in oncology
Published: May 08, 2020
Showing 1-12 of 12

Last Updated: 09/26/2026